Trial Profile
An observation of tofacitinib in patients of MDA5+ clinically amyopathic dermatomyositis with interstitial lung disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2018
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary) ; Glucocorticoids; Immunosuppressants
- Indications Dermatomyositis
- Focus Therapeutic Use
- 21 Jun 2018 New trial record